Inactive Instrument

Company Leisure Acquisition Corp. OTC Markets

Equities

LACQU

US52539T2069

Biotechnology & Medical Research

Business Summary

Ensysce Biosciences, Inc., formerly Leisure Acquisition Corp., is a clinical-stage biotech company. The Company is engaged in the development of small and large molecule drug delivery platforms targeting pain and cancer markets. The primary focus of the Company is its small molecule program developing abuse and overdose resistant pain technology with a clinical stage program being the abuse resistant, trypsin activated abuse protection (TAAP) opioid product candidate, PF614. In addition, the Company is developing multi-pill abuse resistant (MPAR) technology for overdose protection. The Company has also developed a delivery platform for large biomolecules utilizing single walled carbon nanotubes (SWCNT) to produce immunology and gene therapy products.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,585,253 7,410,498 ( 97.70 %) 81 ( 0.001068 %) 97.70 %

Company contact information

Leisure Acquisition Corp.

250 West 57th Street Suite 415

10107, New York

+

http://leisureacq.com/
address Leisure Acquisition Corp.(LACQU)
  1. Stock Market
  2. Equities
  3. LACQ Stock
  4. LACQU Stock
  5. Company Leisure Acquisition Corp.